Erythropoietin stimulation agents significantly improves outcome in lower risk MDS

Garelius, H K G, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Bagguley, Timothy Charles orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2022) Erythropoietin stimulation agents significantly improves outcome in lower risk MDS. HemaSphere. S168. pp. 69-70. ISSN 2572-9241

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Dates:
  • Published: June 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 28 Jun 2022 08:50
Last Modified: 06 Dec 2023 14:45
Published Version: https://doi.org/10.1097/01.hs9.0000843564.40783.b4
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1097/01.hs9.0000843564.40783.b4

Download

Filename: S168_ERYTHROPOIETIN_STIMULATION_AGENTS.69.pdf

Description: S168__ERYTHROPOIETIN_STIMULATION_AGENTS.69

Licence: CC-BY 2.5

Export

Statistics